MedTrace Logo

Assessment of Long-term Effects of Tachosil

NCT05986201 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-08-14

No results posted yet for this study

Summary

This study aimed to analyse the long-term effects of a carrier-bound fibrin sealant (CBFS) after abdominal surgery by following up patients years after application.

Conditions

  • Fibrin Sealant
  • Haemostasis

Interventions

DEVICE

TachoSil®

TachoSil®, a carrier-bound fibrin sealant (CBFS), is a haemostatic tissue sealant composed of a collagen sponge, made from horse tendons, coated on one side with dried human fibrinogen and human thrombin.

Sponsors & Collaborators

  • University of Catania

    lead OTHER

Eligibility

Min Age
32 Years
Max Age
87 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2023-05-01
Completion
2023-06-01
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05986201 on ClinicalTrials.gov